Keith L Brownlie Insider Trading
Get free email notifications about insider trading for Keith L Brownlie.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Keith L Brownlie. Keith L Brownlie is a Director in Celldex Therapeutics, Inc. ($AVAN) and a Director in SOLIGENIX, INC. ($DOR) and a Director in IMMUNE PHARMACEUTICALS INC ($IMNP) and a Director in RXi Pharmaceuticals Corp ($RXII).
Address: 777 OLD SAW MILL RIVER RD TARRYTOWN 10591 NY
Companies in which Keith L Brownlie is an Insider
Celldex Therapeutics, Inc.
Trading Symbol: CLDXIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Keith L Brownlie: Director
Holdings: 10,000 shares
Latest Transaction: Jun 19 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IMMUNE PHARMACEUTICALS INC
Trading Symbol: IMNPIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Keith L Brownlie: Director
Holdings: 360,000 shares
Current Value: $68,400
Latest Transaction: Aug 14 2013
$IMNP Market Capitalization: $23.82M
$IMNP Previous Close: $0.19
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Phio Pharmaceuticals Corp.
Trading Symbol: PHIOIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Keith L Brownlie: Director
Holdings: 20,000 shares
Current Value: $12,800
Latest Transaction: Feb 15 2019
$PHIO Market Capitalization: $4.88M
$PHIO Previous Close: $0.64
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SOLIGENIX, INC.
Trading Symbol: SNGXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Keith L Brownlie: Director
Holdings: 50,000 shares
Latest Transaction: Sep 28 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Keith L Brownlie
Sentiment: All, CLDX, IMNP, PHIO, SNGX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 19 2020 | AVAN | Celldex Therapeuti ... | Brownlie Keith L | Director | Option Exercise | A | 10.38 | 11,000 | 114,180 | 11,000 | |
Jun 20 2019 | AVAN | Celldex Therapeuti ... | Brownlie Keith L | Director | Option Exercise | A | 2.78 | 4,500 | 12,510 | 4,500 | |
Feb 15 2019 | RXII | Phio Pharmaceutica ... | Brownlie Keith L | Director | Grant | A | 0.00 | 10,000 | 0 | 20,000 | 10 K to 20 K (+100.00 %) |
Sep 28 2018 | SNGX | SOLIGENIX, INC. | Brownlie Keith L | Director | Option Exercise | A | 1.67 | 17,964 | 30,000 | 17,964 | |
Aug 03 2018 | RXII | RXi Pharmaceutical ... | Brownlie Keith L | Director | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Jun 15 2018 | AVAN | Celldex Therapeuti ... | Brownlie Keith L | Director | Option Exercise | A | 0.60 | 67,000 | 40,274 | 67,000 | |
Jun 16 2017 | AVAN | Celldex Therapeuti ... | Brownlie Keith L | Director | Option Exercise | A | 2.32 | 8,000 | 18,560 | 8,000 |